Compare UNTY & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNTY | PACB |
|---|---|---|
| Founded | 1991 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.6M | 419.8M |
| IPO Year | 2014 | 2010 |
| Metric | UNTY | PACB |
|---|---|---|
| Price | $51.75 | $1.59 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $65.00 | $1.67 |
| AVG Volume (30 Days) | 42.6K | ★ 6.0M |
| Earning Date | 04-14-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.23% | N/A |
| EPS Growth | ★ 39.66 | N/A |
| EPS | ★ 5.67 | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $12.14 | $11.32 |
| Revenue Next Year | $9.56 | $12.14 |
| P/E Ratio | $9.22 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $41.67 | $0.85 |
| 52 Week High | $57.30 | $2.73 |
| Indicator | UNTY | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 46.34 | 53.32 |
| Support Level | $50.54 | $1.52 |
| Resistance Level | $53.61 | $1.79 |
| Average True Range (ATR) | 1.57 | 0.12 |
| MACD | -0.27 | -0.00 |
| Stochastic Oscillator | 28.36 | 55.32 |
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.